Molecular Bioelectrostatics & Drug Delivery Laboratory
The Bajpayee Lab works at the intersection of biomaterials design, nanomedicine and translational research. We utilize the body’s internal electric fields to design electrically charged biomaterials using proteins, peptides and cellular materials like exosomes, for targeting difficult to reach tissues for applications in drug delivery and diagnostic imaging.
Negatively charged tissues such as cartilage, meniscus, intervertebral disc, eye, and mucosal membrane, that also tend to be dense and avascular, are ubiquitous in the human body but remain outstanding challenges for targeted drug delivery. Their degeneration is associated with several common diseases that remain untreatable due to a lack of delivery systems that can enable drugs to penetrate the negatively charged matrix and reach their cellular targets. The high negative fixed charge density, however, can be converted from being a challenge to an opportunity by engineering therapeutics at the molecular level to add optimally positively charged domains such that electrostatic interactions can enhance their transport, uptake and retention rather than hindering them. Our lab engineers targeted bioelectrical therapeutics for treatment of diseases affecting such intrinsically charged tissues. We strive to combine basic science with translational research to develop biomedical technologies for unmet clinical needs.
Follow us on Twitter @bajpayeelab | @AmbikaBajpayee

We are supported by

Our Lab News
New Review Article on IL-1 inhibition strategies for OA published in Arthritis Research & Therapy!
Congratulations to Dr. Tim Boyer and co-authors for publishing in Arthritis Research & Therapy an insightful and very much needed review on IL-1 inhibition strategies as a therapeutic strategy for OA! IL-1 inhibition has been a widely researched avenue of tackling...
Sustained Release of Neosaxitoxin for OA Pain featured by Nanoscale for US National Nanotechnology Day!
With US National Nanotechnology Day on October 9th, Nanoscale highlighted a series of articles published by US authors in their journals, including our sustained release of neosaxitoxin work led by Dr. Hengli Zhang! Congratulations to Dr. Hengli Zhang and co-authors...
Prof. Bajpayee awarded NIH R01 Grant – Featured on Northeastern COE News!
Our lab has been awarded a $3.1M NIH R01 Grant - Cartilage targeting exosomes for OA gene therapy and pain treatment! This project will continue our work on developing charge-reversed exosomes for non-viral gene therapy in OA. Prof. Rachel Miller from Rush University...






